Cite

HARVARD Citation

    Goto, H. et al. (2020). Feasibility and efficacy of low‐dose pegfilgrastim for CD34+ cell mobilization in lymphoma. Journal of clinical apheresis. 35 (5), pp. 413-419. [Online]. 
  
Back to record